Pharmacological Activation of p53 in Cancer Cells

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|6|631-639

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.6, 2011-02, pp. : 631-639

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p53 Activation by Blocking Snail : A Novel Pharmacological Strategy for Cancer

By  

Current Pharmaceutical Design, Vol. 17, Iss. 6, 2011-02 ,pp. : 610-617

Bentham Science Publishers

Access to resources Recommend Favorite

p53 Regulation of Energy Metabolism and Mitochondria Regulation of p53 in Cancer Cells: An Insight into the Role of Manganese Superoxide Dismutase

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 3, 2013-01 ,pp. : 261-273

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of the p53 pathway in cancer stem cells

By Prabhu Varun V   Allen Joshua E   Hong Bo   Zhang Shengliang   Cheng Hairong   El-Deiry Wafik S  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1161-1174

Informa Healthcare

Access to resources Recommend Favorite

p53: Fighting Cancer

By  

Current Cancer Drug Targets, Vol. 4, Iss. 5, 2004-08 ,pp. : 385-402

Bentham Science Publishers

Access to resources Recommend Favorite

Analogs of Staurosporine - a potent abrogator of G2 checkpoint function in cancer cells with disrupted P53

By Gescher A.  

General Pharmacology, Vol. 31, Iss. 5, 1998-11 ,pp. : 721-728

Elsevier

Access to resources Recommend Favorite